OBERKOCHEN, Germany—President and CEO of Carl Zeiss Meditec AG, Dr. Ludwin Monz, has announced to the company’s supervisory board that he will not be accepting another term in office. Dr. Monz and the supervisory board have agreed to end his term on Dec. 31, 2021. Dr. Monz is currently responsible for the Zeiss Medical Technology segment. He is also president and CEO of the listed company Carl Zeiss Meditec AG. He will be bowing out of this role as well, according to a statement from Zeiss.

Effective Jan. 1, 2022, the supervisory board will be transferring his duties at the Zeiss Medical Technology segment to Dr. Markus Weber. Dr. Weber is currently responsible for the Zeiss Semiconductor Manufacturing Technology segment and will relinquish his current duties on Dec. 31, 2021.

The Supervisory Board has appointed Andreas Pecher to take over from Dr. Weber as head of the Zeiss Semiconductor Manufacturing Technology segment and executive board member of Carl Zeiss AG. Pecher is currently head of the Semiconductor Manufacturing Optics (SMO) strategic business unit. His successor at SMO will be announced in the coming weeks, Zeiss said.